Immune-related adverse events with immune checkpoint inhibitors: Special reference to the effects on the lungs

Immune checkpoint inhibitors (ICIs) have emerged as evolutionary treatments for malignant diseases. Although ICIs can cause immune-related adverse events (irAEs) in various organs, precise timing after ICI initiation has been scarcely reported. Elucidating the effects of irAEs, such as time to onset...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Medicine (Baltimore)
Prif Awduron: Hirata, Aya, Saraya, Takeshi, Kobayashi, Fumi, Noda, Akinari, Aso, Kaori, Sakuma, Sho, Kurokawa, Nozomi, Inoue, Manami, Mikura, Sunao, Oda, Miku, Ishida, Manabu, Honda, Kojiro, Nakamoto, Keitaro, Tamura, Masaki, Takata, Saori, Ishii, Haruyuki, Takizawa, Hajime
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Lippincott Williams & Wilkins 2021
Pynciau:
5700
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8036099/
https://ncbi.nlm.nih.gov/pubmed/33832093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000025275
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg